Foundations of Care

Stopping Zepbound: what happens and how to protect your results

Sword Editorial Team

Enter your employer or health plan

Footnotes

  1. 1

    Prado CM, Wells JC, Smith SR, Stephan BCM, Siervo M. Muscle matters: the effects of medically induced weight loss on skeletal muscle. The Lancet Diabetes & Endocrinology. 2024;12(11):785-787.

  2. 2

    Karakasis P, et al. [Use exact approved source from claims bank for GLP-1 lean mass range before publish.]

  3. 3

    Wilding JPH, Batterham RL, Calanna S, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. https://pubmed.ncbi.nlm.nih.gov/35441470/

  4. 4

    Lundgren JR, et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. New England Journal of Medicine. 2021;384(18):1719-1730.

  5. 5

    Rodriguez PJ, et al. Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity. JAMA Network Open. 2025;8(1):e2457349. doi:10.1001/jamanetworkopen.2024.57349. https://pmc.ncbi.nlm.nih.gov/articles/PMC11786232/

  6. 6

    Sousa AS, et al. Impact of sarcopenia on fall risk: a clinical perspective. Clinical Nutrition ESPEN. 2022;50:63-73.

  7. 7

    Baumgartner RN, et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obesity Research. 2004;12(12):1995-2004.

  8. 8

    Celletti F, Farrar J, De Regil L. World Health Organization guideline on the use and indications of glucagon-like peptide-1 therapies for the treatment of obesity in adults. JAMA. Published online December 1, 2025. doi:10.1001/jama.2025.24288. 

  9. 9

    Jensen SBK, et al. Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment. JAMA Network Open. 2024;7(6):e2416775.

  10. 10

    Sandsdal RM, et al. Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome. Cardiovascular Diabetology. 2023;22:41.

Portugal 2020Norte 2020European UnionPlano de Recuperação e ResiliênciaRepública PortuguesaNext Generation EU